The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts Corrigendum in /10.3892/ijo.2022.5415

Li,Chao; Li,Yan; Lv,Haining; Li,Shaowu; Tang,Ke; Zhou,Wanqi; Yu,Shishan; Chen,Xiaoguang

doi:10.3892/ijo.2015.2977

The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts

Corrigendum in: /10.3892/ijo.2022.5415

Authors:
- Chao Li
- Yan Li
- Haining Lv
- Shaowu Li
- Ke Tang
- Wanqi Zhou
- Shishan Yu
- Xiaoguang Chen
View Affiliations

Affiliations: Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P.R. China, Department of Neurosurgery, Capital Medical University Affiliated Beijing Tiantan Hospital; Beijing Neurosurgical Institute, Beijing 100050, P.R. China
Published online on: April 29, 2015 https://doi.org/10.3892/ijo.2015.2977
Pages: 179-187

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neuroblastoma is the most common cancer in infants and the fourth most common cancer in children. Our previous study showed that PF403 had a potent antitumor ability. In the present study, we evaluated the anti-neuroblastoma property of PF403 and investigated the underlying mechanisms. MTT assay, colony formation assay and flow cytometry assay were used to assess cytotoxicity of PF403 on SH-SY5Y cells. Transwell assay was chosen to estimate the anti-invasion ability of PF403 on neuroblastoma cells. The protein expression was detected by western blot analysis. The SH-SY5Y brain xenograft model was used to assess in vivo antitumor activity of PF403. PF403-mediated SH-SY5Y cell death was found to be dose- and time-dependent, and PF403 was able to limit invasion and metastasis of neuroblastoma cells. MRI and pathology analysis proved that the pro-drug of PF403, CAT3, inhibited SH-SY5Y cells in vivo. PF403 decreased expression of phosphorylated FAK, MMP-2 and MMP-9 proteins, and downregulated the activity of PI3K/AKT and Raf/ERK pathways, followed by regulation of the proteins expression of Bcl-2 family, activated caspase-3, -9 and PARP and initiation of apoptosis of neuroblastoma cells. PF403 exerted cytotoxicity against SH-SY5Y neuroblastoma cell both in vitro and in vivo, and inhibited its invasion ability, suggesting PF403 has potential as a new anticancer drug for the treatment of neuroblastoma.

View Figures

View References

1	Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003. View Article : Google Scholar : PubMed/NCBI
2	Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
3	Chemler SR: Phenanthroindolizidines and phenanthroquinolizidines: promising alkaloids for anti-cancer therapy. Curr Bioact Compd. 5:2–19. 2007. View Article : Google Scholar
4	Fu Y, Lee SK, Min HY, Lee T, Lee J, Cheng M and Kim S: Synthesis and structure-activity studies of antofine analogues as potential anticancer agents. Bioorg Med Chem Lett. 17:97–100. 2007. View Article : Google Scholar
5	Gao W, Bussom S, Grill SP, Gullen EA, Hu YC, Huang X, Zhong S, Kaczmarek C, Gutierrez J, Francis S, et al: Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents. Bioorg Med Chem Lett. 17:4338–4342. 2007. View Article : Google Scholar : PubMed/NCBI
6	Xi Z, Zhang R, Yu Z and Ouyang D: The interaction between tylophorine B and TMV RNA. Bioorg Med Chem Lett. 16:4300–4304. 2006. View Article : Google Scholar : PubMed/NCBI
7	Liu ZJ, Lv HN, Li HY, Zhang Y, Zhang HJ, Su FQ, Si YK, Yu SS and Chen XG: Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids. J Asian Nat Prod Res. 13:400–408. 2011. View Article : Google Scholar : PubMed/NCBI
8	Lv H, Ren J, Ma S, Xu S, Qu J, Liu Z, Zhou Q, Chen X and Yu S: Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents. PLoS One. 7:e303422012. View Article : Google Scholar : PubMed/NCBI
9	Yu P, Li C, Ren J, Ma S, Song X, Chen X and Yu S: Stereospecific synthesis and biological evaluation of monodesmethyl metabolites of (+)-13a-(S)-deoxytylophorinine as potential antitumor agents. Synthesis. 44:3757–3764. 2012. View Article : Google Scholar
10	Mon NN, Ito S, Senga T and Hamaguchi M: FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann NY Acad Sci. 1086:199–212. 2006. View Article : Google Scholar : PubMed/NCBI
11	Shibata K, Kikkawa F, Nawa A, Thant AA, Naruse K, Mizutani S and Hamaguchi M: Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. 58:900–903. 1998.PubMed/NCBI
12	Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF and Livant DL: Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor- mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res. 66:8091–8099. 2006. View Article : Google Scholar : PubMed/NCBI
13	De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, Di Cataldo A, et al: Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol. 21:1592–1601. 2003. View Article : Google Scholar : PubMed/NCBI
14	Pardridge WM: The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2:3–14. 2005. View Article : Google Scholar : PubMed/NCBI
15	Pardridge WM: Molecular Trojan horses for blood-brain barrier drug delivery. Curr Opin Pharmacol. 6:494–500. 2006. View Article : Google Scholar : PubMed/NCBI
16	Pardridge WM: Biopharmaceutical drug targeting to the brain. J Drug Target. 18:157–167. 2010. View Article : Google Scholar : PubMed/NCBI
17	Yount G, Taft RJ, Luu T, Rachlin K, Moore D and Zhang W: Independent motile microplast formation correlates with glioma cell invasiveness. J Neurooncol. 81:113–121. 2007. View Article : Google Scholar
18	Canel M, Secades P, Garzón-Arango M, Allonca E, Suarez C, Serrels A, Frame M, Brunton V and Chiara MD: Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer. 98:1274–1284. 2008. View Article : Google Scholar : PubMed/NCBI
19	Sun T, Zhao N, Ni CS, Zhao XL, Zhang WZ, Su X, Zhang DF, Gu Q and Sun BC: Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK). Cancer Lett. 285:141–150. 2009. View Article : Google Scholar : PubMed/NCBI
20	Mon NN, Hasegawa H, Thant AA, Huang P, Tanimura Y, Senga T and Hamaguchi M: A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res. 66:6778–6784. 2006. View Article : Google Scholar : PubMed/NCBI
21	Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS, Wu SH and Chung JG: Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agric Food Chem. 58:2935–2942. 2010. View Article : Google Scholar : PubMed/NCBI
22	Zhang Y, Thant AA, Hiraiwa Y, Naito Y, Sein TT, Sohara Y, Matsuda S and Hamaguchi M: A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. Biochem Biophys Res Commun. 290:1123–1127. 2002. View Article : Google Scholar : PubMed/NCBI
23	Chang YM, Shih YT, Chen YS, Liu CL, Fang WK, Tsai CH, Tsai FJ, Kuo WW, Lai TY and Huang CY: Schwann cell migration induced by earthworm extract via activation of PAs and MMP-2/9 mediated through ERK1/2 and p38. Evid Based Complement Alternat Med. 2011:3954582011. View Article : Google Scholar
24	Choi YA, Lim HK, Kim JR, Lee CH, Kim YJ, Kang SS and Baek SH: Group IB secretory phospholipase A2 promotes matrix metalloproteinase-2-mediated cell migration via the phosphatidylinositol 3-kinase and Akt pathway. J Biol Chem. 279:36579–36585. 2004. View Article : Google Scholar : PubMed/NCBI
25	Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, Zhao YZ, Wang Z, Chen F, Lee KY, et al: Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer. 101:327–334. 2009. View Article : Google Scholar : PubMed/NCBI
26	Chan KC, Ho HH, Huang CN, Lin MC, Chen HM and Wang CJ: Mulberry leaf extract inhibits vascular smooth muscle cell migration involving a block of small GTPase and Akt/NF-kappaB signals. J Agric Food Chem. 57:9147–9153. 2009. View Article : Google Scholar : PubMed/NCBI
27	Green DR and Kroemer G: The Pathophysiology of mitochondrial cell death. Science. 305:626–629. 2004. View Article : Google Scholar : PubMed/NCBI
28	Kuwana T and Newmeyer DD: Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol. 15:691–699. 2003. View Article : Google Scholar : PubMed/NCBI
29	Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ and Cheng EH: BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science. 330:1390–1393. 2010. View Article : Google Scholar : PubMed/NCBI
30	Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:727–730. 2001. View Article : Google Scholar : PubMed/NCBI
31	Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:285–291. 1995. View Article : Google Scholar : PubMed/NCBI
32	Zhivotovsky B, Samali A, Gahm A and Orrenius S: Caspases their intracellular localization and translocation during apoptosis. Cell Death Differ. 6:644–651. 1999. View Article : Google Scholar : PubMed/NCBI